365 related articles for article (PubMed ID: 27126234)
1. Deciphering intratumor heterogeneity using cancer genome analysis.
Ryu D; Joung JG; Kim NK; Kim KT; Park WY
Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
[TBL] [Abstract][Full Text] [Related]
2. Multiregional Tumor Trees Are Not Phylogenies.
Alves JM; Prieto T; Posada D
Trends Cancer; 2017 Aug; 3(8):546-550. PubMed ID: 28780931
[TBL] [Abstract][Full Text] [Related]
3. CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.
Yu Z; Li A; Wang M
BMC Bioinformatics; 2016 Aug; 17():310. PubMed ID: 27538789
[TBL] [Abstract][Full Text] [Related]
4. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
5. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.
Fan J; Lee HO; Lee S; Ryu DE; Lee S; Xue C; Kim SJ; Kim K; Barkas N; Park PJ; Park WY; Kharchenko PV
Genome Res; 2018 Aug; 28(8):1217-1227. PubMed ID: 29898899
[TBL] [Abstract][Full Text] [Related]
6. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
[TBL] [Abstract][Full Text] [Related]
7. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.
Fan Y; Xi L; Hughes DS; Zhang J; Zhang J; Futreal PA; Wheeler DA; Wang W
Genome Biol; 2016 Aug; 17(1):178. PubMed ID: 27557938
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Genetic Analysis Using Automated Microfluidics to Resolve Somatic Mosaicism.
Szulwach KE; Chen P; Wang X; Wang J; Weaver LS; Gonzales ML; Sun G; Unger MA; Ramakrishnan R
PLoS One; 2015; 10(8):e0135007. PubMed ID: 26302375
[TBL] [Abstract][Full Text] [Related]
9. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
Zhang X; Lv D; Zhang Y; Liu Q; Li Z
Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
[TBL] [Abstract][Full Text] [Related]
10. Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer.
Yin X; Jing Y; Cai MC; Ma P; Zhang Y; Xu C; Zhang M; Di W; Zhuang G
Cancer Res; 2017 Dec; 77(23):6551-6561. PubMed ID: 28972072
[TBL] [Abstract][Full Text] [Related]
11. Multiregion Sequence Analysis to Predict Intratumor Heterogeneity and Clonal Evolution.
Ahn S; Huang H
Methods Mol Biol; 2021; 2243():283-296. PubMed ID: 33606263
[TBL] [Abstract][Full Text] [Related]
12. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.
Jiang Y; Qiu Y; Minn AJ; Zhang NR
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852
[TBL] [Abstract][Full Text] [Related]
13. A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
Saito T; Niida A; Uchi R; Hirata H; Komatsu H; Sakimura S; Hayashi S; Nambara S; Kuroda Y; Ito S; Eguchi H; Masuda T; Sugimachi K; Tobo T; Nishida H; Daa T; Chiba K; Shiraishi Y; Yoshizato T; Kodama M; Okimoto T; Mizukami K; Ogawa R; Okamoto K; Shuto M; Fukuda K; Matsui Y; Shimamura T; Hasegawa T; Doki Y; Nagayama S; Yamada K; Kato M; Shibata T; Mori M; Aburatani H; Murakami K; Suzuki Y; Ogawa S; Miyano S; Mimori K
Nat Commun; 2018 Jul; 9(1):2884. PubMed ID: 30038269
[TBL] [Abstract][Full Text] [Related]
14. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
Yu Z; Li A; Wang M
BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
[TBL] [Abstract][Full Text] [Related]
15. Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.
Árnadóttir SS; Jeppesen M; Lamy P; Bramsen JB; Nordentoft I; Knudsen M; Vang S; Madsen MR; Thastrup O; Thastrup J; L Andersen C
Mol Oncol; 2018 Jan; 12(1):132-147. PubMed ID: 29130628
[TBL] [Abstract][Full Text] [Related]
16. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.
Deshwar AG; Vembu S; Yung CK; Jang GH; Stein L; Morris Q
Genome Biol; 2015 Feb; 16(1):35. PubMed ID: 25786235
[TBL] [Abstract][Full Text] [Related]
17. Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator.
Oh BY; Shin HT; Yun JW; Kim KT; Kim J; Bae JS; Cho YB; Lee WY; Yun SH; Park YA; Park YH; Im YH; Lee J; Joung JG; Kim HC; Park WY
Sci Rep; 2019 Mar; 9(1):4542. PubMed ID: 30872730
[TBL] [Abstract][Full Text] [Related]
18. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
Gupta RG; Somer RA
Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
[TBL] [Abstract][Full Text] [Related]
19. Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors.
Saber A; Hiltermann TJN; Kok K; Terpstra MM; de Lange K; Timens W; Groen HJM; van den Berg A
Carcinogenesis; 2017 Feb; 38(2):144-151. PubMed ID: 27993895
[TBL] [Abstract][Full Text] [Related]
20. Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity.
Shi W; Ng CKY; Lim RS; Jiang T; Kumar S; Li X; Wali VB; Piscuoglio S; Gerstein MB; Chagpar AB; Weigelt B; Pusztai L; Reis-Filho JS; Hatzis C
Cell Rep; 2018 Nov; 25(6):1446-1457. PubMed ID: 30404001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
